Samantha O Luk (Samantha Luk)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Chemotherapy Induced

Hematopoietic Stem Cell

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Shuroug A Alowais, Samantha O Luk, E Bridget Kim, Nada Alsuhebany, Mark Zangardi
Late-onset cardiotoxicity in patients with HER2-positive metastatic breast cancer receiving trastuzumab-based therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Jack Malespini, Matthew M Lei, Erica Tavares, Sarah P Hammond, Yi-Bin Chen, Samantha O Luk, Zachariah DeFilipp
Letermovir and tacrolimus interaction effects in hematopoietic cell transplantation recipients receiving moderate cytochrome P450 3A4 inhibitors for antifungal prophylaxis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Neelam A Phadke, Samantha O Luk, Ephraim P Hochberg, Aleena Banerji
Immediate reaction to ibrutinib amenable to oral desensitization. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (7) (2021)
Jenna Lam, Erica Tavares, Samantha O Luk
Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT). Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (6) (2020)
Jessie R Signorelli, Samantha O Luk, Erica Tavares, Gabriela S Hobbs
Antiemetic prophylaxis for induction chemotherapy in patients with acute myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2020)